Skip to main content
Geneuro logo

Geneuro — Investor Relations & Filings

Ticker · GEM ISIN · CH0308403085 LEI · 213800FUJCKXO9LK3444 PA Professional, scientific and technical activities
Open in API
Filings indexed 221 across all filing types
Latest filing 2026-01-28 Regulatory Filings
Country CH Switzerland
Listing PA GEM

About Geneuro

https://geneuro.ch/en/

Geneuro is a clinical-stage biopharmaceutical company developing treatments for neurological and autoimmune diseases. The company's approach focuses on neutralizing pathogenic proteins expressed by human endogenous retroviruses (HERVs), which are believed to be causal factors in the progression of certain diseases. Its primary areas of development include conditions such as multiple sclerosis (MS) and post-COVID syndrome (long-COVID). Geneuro's lead product candidate, temelimab, is a monoclonal antibody designed to target and neutralize a specific HERV envelope protein. This strategy aims to block the inflammatory and neurodegenerative processes associated with these diseases, representing a precision medicine approach to treatment.

Recent filings

Filing Released Lang Actions
INFORMATIONS PRIVILÉGIÉES / AUTRES COMMUNIQUÉS
Regulatory Filings Classification · 1% confidence The document is a press release announcing the bankruptcy of GeNeuro SA following the expiration of a moratorium period. It does not fit into specific categories like M&A, earnings, or governance. As it is a significant regulatory announcement regarding the company's legal status and existence, and does not fit into the other specialized categories, it is classified as a Regulatory Filing (RNS).
2026-01-28 French
INSIDE INFORMATION / OTHER NEWS RELEASES
Regulatory Filings Classification · 1% confidence The document is a press release announcing that GeNeuro SA has been declared bankrupt by the Geneva Court of First Instance following the end of a debt moratorium. This is a significant regulatory announcement regarding the company's status and financial viability. Since it does not fit into specific categories like M&A, share issues, or financial reports, and serves as a formal regulatory disclosure of a material event, it is best classified as a Regulatory Filing (RNS).
2026-01-28 English
Inside Information / Other news releases
Regulatory Filings Classification · 1% confidence The document is a press release from GeNeuro SA announcing a request for a temporary suspension of trading of its shares on Euronext Paris pending a court judgment regarding its debt moratorium. This is a regulatory announcement concerning the status of the company's stock on an exchange and its ongoing legal/financial restructuring process. Since it does not fit into specific categories like 'Delisting' (as it is a temporary suspension) or 'Legal Proceedings' (which usually refers to litigation outcomes rather than market status), it falls under the 'Regulatory Filings' (RNS) category as a general corporate announcement.
2026-01-23 English
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 1% confidence The document is a press release from GeNeuro SA announcing a temporary suspension of its stock trading on Euronext Paris pending a court judgment regarding its 'sursis concordataire' (a Swiss legal procedure for debt restructuring/bankruptcy prevention). Since this is a regulatory announcement regarding trading status and corporate legal proceedings that does not fit into specific categories like M&A or financial reporting, it is classified as a general regulatory filing.
2026-01-23 French
Franchissement de seuils
Major Shareholding Notification Classification · 1% confidence The document is a formal notification regarding a change in share ownership (crossing thresholds) for the company GENEURO SA. It explicitly references 'Déclaration de franchissement de seuils' (Declaration of crossing thresholds) under article L. 233-7 of the French Commercial Code. This aligns perfectly with the definition of a Major Shareholding Notification.
2025-12-15 French
Informations privilégiées / Autres communiqués
Report Publication Announcement Classification · 1% confidence The document is a press release from GeNeuro SA announcing the postponement of the publication of its half-year financial report. It does not contain the financial report itself, but rather serves as an official notification regarding the timing and status of the report's release. According to the 'Menu vs Meal' rule, an announcement regarding the timing or publication of a report is classified as a Report Publication Announcement (RPA).
2025-10-15 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.